跳至主要内容
临床试验/NL-OMON55914
NL-OMON55914招募中3 期

Protecting late-moderate preterm infants from respiratory tract infections and wheeze in their first yearsof life by using bacterial lysates. - PROTEA

Franciscus Gasthuis & Vlietland0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0(—)

入选标准

  • Gestational age at delivery between 30+0 and 35+6 weeks
  • Postnatal age at least 6 weeks at randomization & postmenstrual age at least 37
  • Written informed consent by both parents or formal caregivers

排除标准

  • Underlying other severe respiratory disease such as broncho-pulmonary dysplasia
  • (unexpected in this group); hemodynamic significant cardiac disease;
  • immunodeficiency; severe failure to thrive; birth asphyxia with predicted poor
  • neurological out-come; syndrome or serious congenital disorder.
  • Dysmaturity and/or weight < 2.5 kg at age of randomization.
  • Maternal TNF-alpha inhibitors or other immunosuppression during pregnancy
  • and/or breastfeeding
  • Parents unable to speak and read Dutch/English language
  • Known allergic hypersensitivity to the active ingredients/substance or to any
  • of the excipients.

研究者

相似试验

Protecting late-moderate preterm infants from... | 临床试验